Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/42996
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Metcalf, Daniel J. | en_US |
dc.contributor.author | García-Arencibia, Moisés | en_US |
dc.contributor.author | Hochfeld, Warren E. | en_US |
dc.contributor.author | Rubinsztein, David C. | en_US |
dc.contributor.other | Garcia-Arencibia, Moises | - |
dc.date.accessioned | 2018-11-21T12:00:56Z | - |
dc.date.available | 2018-11-21T12:00:56Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.issn | 0014-4886 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/42996 | - |
dc.description.abstract | The accumulation of misfolded proteins in insoluble aggregates within the neuronal cytoplasm is one of the common pathological hallmarks of most adult-onset human neurodegenerative diseases. The clearance of these misfolded proteins may represent a promising therapeutic strategy in these diseases. The two main routes for intracellular protein degradation are the ubiquitin-proteasome and the autophagy-lysosome pathways. In this review, we will focus on the autophagic pathway, by providing some examples of how impairment at different steps in this degradation pathway is related to different neurodegenerative diseases. We will also consider that upregulating autophagy may be useful in the treatment of some of these diseases. Finally, we discuss how antioxidants, which have been considered to be beneficial in neurodegenerative diseases, can block autophagy, thus potentially compromising their therapeutic potential. | en_US |
dc.language | eng | en_US |
dc.publisher | 0014-4886 | - |
dc.relation.ispartof | Experimental neurology | en_US |
dc.source | Experimental Neurology [ISSN 0014-4886], v. 238, p. 22-28 | en_US |
dc.subject | 320507 Neurología | en_US |
dc.subject.other | Autophagy | en_US |
dc.subject.other | Neurodegeneration | en_US |
dc.subject.other | Huntington's disease | en_US |
dc.title | Autophagy and misfolded proteins in neurodegeneration | en_US |
dc.type | info:eu-repo/semantics/review | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.expneurol.2010.11.003 | en_US |
dc.identifier.scopus | 84866550924 | - |
dc.identifier.isi | 000309625400003 | - |
dcterms.isPartOf | Experimental Neurology | - |
dcterms.source | Experimental Neurology[ISSN 0014-4886],v. 238 (1), p. 22-28 | - |
dc.contributor.authorscopusid | 55756351900 | - |
dc.contributor.authorscopusid | 15821889300 | - |
dc.contributor.authorscopusid | 35745995900 | - |
dc.contributor.authorscopusid | 7006338728 | - |
dc.description.lastpage | 28 | en_US |
dc.description.firstpage | 22 | en_US |
dc.relation.volume | 238 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Reseña | en_US |
dc.identifier.wos | WOS:000309625400003 | - |
dc.contributor.daisngid | 2938763 | - |
dc.contributor.daisngid | 4144634 | - |
dc.contributor.daisngid | 5008687 | - |
dc.contributor.daisngid | 37428 | - |
dc.identifier.investigatorRID | K-9920-2013 | - |
dc.utils.revision | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.description.sjr | 2,124 | |
dc.description.jcr | 4,645 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.orcid | 0000-0002-1618-4487 | - |
crisitem.author.fullName | García Arencibia, Moisés | - |
Colección: | Reseña |
Citas SCOPUSTM
109
actualizado el 17-nov-2024
Citas de WEB OF SCIENCETM
Citations
103
actualizado el 17-nov-2024
Visitas
67
actualizado el 16-nov-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.